Clinical trial
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are…
NCT00311636 · Gruppo Italiano Mammella (GIM), Other · Completed
Key facts
| NCT number | NCT00311636 |
|---|---|
| Title | Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery |
| Official title | Prevention of Chemotherapy-induced Menopause by Temporary Ovarian Suppression With Triptorelin Vs. Control in Young Breast Cancer Patients. A Randomized Phase III Multicenter Study [PROMISE] |
| Lead sponsor | Gruppo Italiano Mammella (GIM), Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cyclophosphamide, docetaxel, doxorubicin hydrochloride, epirubicin hydrochloride, fluorouracil, methotrexate, paclitaxel, triptorelin, adjuvant therapy |
| Enrollment | 280 |
| Start date | Sep 1, 2003 |
| Primary completion | Jan 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Apr 6, 2006 |
| Last update posted | Jun 26, 2013 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: